Ekso Bionics (EKSO) Tops Q3 EPS by 7c

Ekso Bionics (NASDAQ: EKSO) reported Q3 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Tesla Q2 deliveries: What to expect from the critical report
• Hormel Foods agrees to sell Brazil's Ceratti brand to Zanchetta